医学
神经母细胞瘤
化疗
耐火材料(行星科学)
阶段(地层学)
养生
外科
实体瘤
化疗方案
疾病
内科学
癌症
天体生物学
物理
遗传学
古生物学
生物
细胞培养
作者
Rejin Kebudi,Begüm Şirin Koç,Banu Oflaz Sözmen
出处
期刊:Current Pediatric Reviews
[Bentham Science]
日期:2023-11-06
卷期号:21 (2): 186-191
标识
DOI:10.2174/0115733963255648231024081333
摘要
Neuroblastoma is the most common extra-cranial solid tumor in children. The survival rate of relapsed/refractory neuroblastoma is dismal. Late recurrence may occur rarely.We have, herein, presented a case with stage IV neuroblastoma who relapsed after 11 years and had a subsequent relapse after 15 years from the initial diagnosis, and reviewed cases with late relapsed (after >5 years) neuroblastoma in the literature. The case presented with recurrent disease at the T7 vertebra after 11 years from the initial diagnosis. The patient received surgery, chemotherapy, MIBG treatment, and antiGD2 combined with chemotherapy, and had a further local recurrence in the paravertebral area of the removed T7 vertebra after three years. The patient was operated, received anti-GD2 combined with chemotherapy, and is still alive with no symptoms for 19 months after the last relapse.There is not a well-established treatment regimen for the majority of these patients. MIBG treatment and antiGD2 combined with chemotherapy may be promising options for relapsed/ refractory neuroblastoma.
科研通智能强力驱动
Strongly Powered by AbleSci AI